Sunday was so quiet that even payouts couldn’t be bothered to move: networks are yawning, offers are keeping their mouths shut, and Ryzhik is already counting not money, but pauses.

🛋️ Four networks did something, but without much enthusiasm

Over the last 24 hours, 4 networks made moves, and when it comes to the important stuff, it was almost museum-grade: offers +1/−1, goals +1/−4, payouts ↑0 ↓0. In other words, the market didn’t die — it just flopped onto the rug and is pretending that’s a strategy.

🪱 Italy got a new nutra tenant

In MetaCPA IT, Puricore parasites showed up for 29 EUR in Italy. Nutra, as always, cures everything under the sun — now apparently parasites too. Looks like someone decided Italians needed not coffee after the weekend, but an anti-parasite romance.

🗑️ Admitad took the Russian app update out of the catalog

Admitad pulled the Russian offer from the apps category. The name sounds like this wasn’t a product, but a passport office wrapped in CPA glue. Sunday clearly decided apps deserve a day off too, and the catalog could use a little less noise.

👀 Oculax’s eyesight is a bit off

For Oculax in KMA, goals dropped by −3 in ee, lt, lv. Vision capsules that can’t even see demand anymore — that’s practically meta-nutra. The Baltics, apparently, looked at the offer and said: “No thanks, we can see just fine.”

💪 VIGORPLUS potency also showed up without fanfare

For VIGORPLUS from T-Light, another −1 goal disappeared in td. For capsules with a name like that, it’s especially painful: they promised vigor, and got one fewer taker instead. The Sunday market, as usual, doesn’t believe in miracles or in “effort.”

🥀 Puricore still managed to perk up a little

The same Puricore in MetaCPA posted +1 goal in IT. A tiny plus, but against the general sleepiness it’s like a kitten in an empty office: didn’t wake anyone up, but it’s still nice that something moved. Otherwise, the whole day was just partner-network snoring.